Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma
NCT ID: NCT05452382
Last Updated: 2022-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2607 participants
OBSERVATIONAL
2005-01-01
2022-07-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Clinical Characteristics and Pathological Findings in Patients With Suspected Appendicitis
NCT06462846
Pancreatic Surgery in Elderly Patients
NCT04893408
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
NCT06369480
Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate
NCT04802993
Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy
NCT05489458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Partial colectomy
Patients with appendiceal cancer who underwent segmental resection of appendiceal adenocarcinoma
Partial colecctomy
Segmental resection of appendiceal adenocarcinoma including terminal ileum and cecum
Hemicolectomy
Patients with appendiceal cancer who underwent formal right hemicolectomy of appendiceal adenocarcinoma
Hemicolectomy
Formal right hemicolectomy including terminal ileum, cecum, and ascending colon
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Partial colecctomy
Segmental resection of appendiceal adenocarcinoma including terminal ileum and cecum
Hemicolectomy
Formal right hemicolectomy including terminal ileum, cecum, and ascending colon
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with clinical stage IV or unknown stage
* Patients who did not undergo surgery, underwent local excision, or had unknown/non-specified surgery
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cleveland Clinic Florida
OTHER
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sameh Emile
Research associate
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic Flroida
Weston, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCDBAppendix
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.